These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3601011

  • 1. Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice.
    Moroji T, Hagino Y.
    Neuropeptides; 1987 Apr; 9(3):217-24. PubMed ID: 3601011
    [Abstract] [Full Text] [Related]

  • 2. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T, Hagino Y.
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T, Ikeda M, Matsubara K, Matsushita A.
    Eur J Pharmacol; 1993 Jan 19; 230(3):271-7. PubMed ID: 8440305
    [Abstract] [Full Text] [Related]

  • 4. Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze.
    Vasar E, Lang A, Harro J, Kõks S, Volke V, Sihver S, Bourin M, Bradwejn J, Männistö PT.
    Neuropeptides; 1994 Jan 19; 26(1):39-45. PubMed ID: 8159285
    [Abstract] [Full Text] [Related]

  • 5. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
    Hagino Y, Moroji T, Iizuka R.
    Neuropeptides; 1989 Jan 19; 13(2):107-13. PubMed ID: 2739882
    [Abstract] [Full Text] [Related]

  • 6. Behavioral effect of cholecystokinin octapeptide in vagotomized rats.
    Itoh S, Katsuura G.
    Can J Physiol Pharmacol; 1986 Jun 19; 64(6):745-7. PubMed ID: 3756626
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of antagonism between ceruletide and various central-acting drugs: investigation by means of ambulatory activity in mice].
    Ida I, Asami T, Kuribara H, Machiyama Y, Tadokoro S.
    Nihon Yakurigaku Zasshi; 1990 Dec 19; 96(6):333-41. PubMed ID: 2076853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contrasting effects on methamphetamine sensitization of ceruletide, a cholecystokinin-like decapeptide, and haloperidol.
    Kuribara H.
    Psychopharmacology (Berl); 1995 Jul 19; 120(1):75-80. PubMed ID: 7480538
    [Abstract] [Full Text] [Related]

  • 10. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
    Hagino Y, Moroji T.
    Brain Res; 1994 Apr 25; 644(1):40-6. PubMed ID: 8032948
    [Abstract] [Full Text] [Related]

  • 11. Systemic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils.
    Eigyo M, Katsuura G, Shintaku H, Shinohara S, Katoh A, Shiomi T, Matsushita A.
    Eur J Pharmacol; 1992 Apr 22; 214(2-3):149-58. PubMed ID: 1516636
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-lasting inhibitory action of caerulein on climbing fiber system in the cerebellum of the rat.
    Kageyama H, Kurosawa A.
    Neuropharmacology; 1989 Sep 22; 28(9):991-5. PubMed ID: 2554189
    [Abstract] [Full Text] [Related]

  • 15. Central effects of ceruletide analogues.
    Zetler G.
    Peptides; 1981 Sep 22; 2 Suppl 2():65-9. PubMed ID: 6283499
    [Abstract] [Full Text] [Related]

  • 16. Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis.
    Hamamura T, Kazahaya Y, Otsuki S.
    Brain Res; 1989 Mar 27; 483(1):78-83. PubMed ID: 2706512
    [Abstract] [Full Text] [Related]

  • 17. Omega-conotoxin GVIA inhibits the methylphenidate-induced but not methamphetamine-induced behavior.
    Yamada K, Teraoka T, Morita S, Hasegawa T, Nabeshima T.
    Neurosci Lett; 1994 Jan 03; 165(1-2):191-4. PubMed ID: 8015724
    [Abstract] [Full Text] [Related]

  • 18. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
    Smith GP, Jerome C, Kulkosky P, Simansky KJ.
    Peptides; 1984 Jan 03; 5(6):1149-57. PubMed ID: 6099563
    [Abstract] [Full Text] [Related]

  • 19. Differential antagonism of the stimulant effects of MK-801 and methamphetamine by ceruletide: evaluation by discrete shuttle avoidance response in mice.
    Kuribara H, Tadokoro S.
    Jpn J Pharmacol; 1991 Nov 03; 57(3):425-9. PubMed ID: 1813668
    [Abstract] [Full Text] [Related]

  • 20. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G, Itoh S.
    Jpn J Physiol; 1982 Nov 03; 32(1):83-91. PubMed ID: 6281507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.